Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Lanzillo

Showing results (21-30 of 210) with videos related to

Pageof 21
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2026
A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosisMarcello Moccia, Chiara Clemente, Simone Braca, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosisAntonio Carotenuto, Elisabetta Signoriello, Roberta Lanzillo, et al.
Brain Sciences|October 2, 2019
Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10Marcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
BMC Health Services Research|August 28, 2020
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)Marcello Moccia, Ilaria Loperto, Roberta Lanzillo, et al.
Frontiers in Neurology|July 5, 2017
Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry StudyGiuseppe Pontillo, Sirio Cocozza, Roberta Lanzillo, et al.
Frontiers in Neurology|July 7, 2020
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 TrialsMarcello Moccia, Roberta Lanzillo, Martina Petruzzo, et al.
Journal of the Neurological Sciences|June 11, 2022
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case seriesMarcello Moccia, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Children (Basel, Switzerland)|June 2, 2021
Needs and Experiences of Children and Adolescents with Pediatric Multiple Sclerosis and Their Caregivers: A Systematic ReviewShashank Ghai, Elisabeth Kasilingam, Roberta Lanzillo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 9, 2016
Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilienceNunzia Rainone, Alessandro Chiodi, Roberta Lanzillo, et al.
Computer Methods and Programs in Biomedicine|June 30, 2022
A polynomial regression-based approach to estimate relaxation rate maps suitable for multiparametric segmentation of clinical brain MRI studies in multiple sclerosisMaria Agnese Pirozzi, Mario Tranfa, Mario Tortora, et al.
Pageof 21

Showing results (21-30 of 210) with videos related to

Sort By:
Pageof 21
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 3, 2026
A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosisMarcello Moccia, Chiara Clemente, Simone Braca, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosisAntonio Carotenuto, Elisabetta Signoriello, Roberta Lanzillo, et al.
Brain Sciences|October 2, 2019
Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10Marcello Moccia, Antonio Capacchione, Roberta Lanzillo, et al.
BMC Health Services Research|August 28, 2020
Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)Marcello Moccia, Ilaria Loperto, Roberta Lanzillo, et al.
Frontiers in Neurology|July 5, 2017
Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry StudyGiuseppe Pontillo, Sirio Cocozza, Roberta Lanzillo, et al.
Frontiers in Neurology|July 7, 2020
Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 TrialsMarcello Moccia, Roberta Lanzillo, Martina Petruzzo, et al.
Journal of the Neurological Sciences|June 11, 2022
Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case seriesMarcello Moccia, Antonio Riccardo Buonomo, Riccardo Scotto, et al.
Children (Basel, Switzerland)|June 2, 2021
Needs and Experiences of Children and Adolescents with Pediatric Multiple Sclerosis and Their Caregivers: A Systematic ReviewShashank Ghai, Elisabeth Kasilingam, Roberta Lanzillo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 9, 2016
Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilienceNunzia Rainone, Alessandro Chiodi, Roberta Lanzillo, et al.
Computer Methods and Programs in Biomedicine|June 30, 2022
A polynomial regression-based approach to estimate relaxation rate maps suitable for multiparametric segmentation of clinical brain MRI studies in multiple sclerosisMaria Agnese Pirozzi, Mario Tranfa, Mario Tortora, et al.
Pageof 21